Response by Jeon and Oh to Letter Regarding Article, "Anti-Inflammatory Actions of Soluble Ninjurin-1 Ameliorate Atherosclerosis"

Affiliations

Comment

Sejin Jeon et al. Circulation. 2021.

. 2021 May 11;143(19):e921-e922.

doi: 10.1161/CIRCULATIONAHA.121.053671. Epub 2021 May 10.

¹ Immune and Vascular Cell Network Research Center, National Creative Initiatives, Department of Life Sciences, Ewha Womans University, Seoul, Korea.

No abstract available

Comment on

Anti-Inflammatory Actions of Soluble Ninjurin-1 Ameliorate Atherosclerosis.
Jeon S, Kim TK, Jeong SJ, Jung IH, Kim N, Lee MN, Sonn SK, Seo S, Jin J, Kweon HY, Kim S, Shim D, Park YM, Lee SH, Kim KW, Cybulsky MI, Shim H, Roh TY, Park WY, Lee HO, Choi JH, Park SH, Oh GT. Jeon S, et al. Circulation. 2020 Nov 3;142(18):1736-1751. doi: 10.1161/CIRCULATIONAHA.120.046907. Epub 2020 Sep 4. Circulation. 2020. PMID: 32883094
Letter by Ji and Zheng Regarding Article, "Anti-Inflammatory Actions of Soluble Ninjurin-1 Ameliorate Atherosclerosis".
Ji L, Zheng Y. Ji L, et al. Circulation. 2021 May 11;143(19):e917-e918. doi: 10.1161/CIRCULATIONAHA.120.051731. Epub 2021 May 10. Circulation. 2021. PMID: 33970673 No abstract available.
Letter by Wu et al Regarding Article, "Anti-Inflammatory Actions of Soluble Ninjurin-1 Ameliorate Atherosclerosis".
Wu Z, Zhang W, Yang J. Wu Z, et al. Circulation. 2021 May 11;143(19):e919-e920. doi: 10.1161/CIRCULATIONAHA.120.053212. Epub 2021 May 10. Circulation. 2021. PMID: 33970674 No abstract available.